HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giuseppe Mancia Selected Research

Nifedipine (Adalat)

1/2016Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses.
6/2015Ambulatory blood pressure in untreated and treated hypertensive patients at high altitude: the High Altitude Cardiovascular Research-Andes study.
12/2014Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results.
1/2012Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT.
3/2011Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study.
12/2004Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial.
2/2004Effects of the combination of low-dose nifedipine GITS 20 mg and losartan 50 mg in patients with mild to moderate hypertension.
4/2003Combination of lisinopril and nifedipine GITS increases blood pressure control compared with single drugs in essential hypertensive patients.
3/2003Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT).
3/2002Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giuseppe Mancia Research Topics

Disease

162Hypertension (High Blood Pressure)
01/2022 - 03/2002
53Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2006
44Cardiovascular Diseases (Cardiovascular Disease)
04/2022 - 09/2002
38Heart Failure
01/2022 - 04/2002
35Vascular Diseases (Vascular Disease)
01/2022 - 04/2009
31Stroke (Strokes)
04/2022 - 06/2002
23Obesity
01/2022 - 09/2003
22Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2020 - 09/2006
17Atherosclerosis
01/2020 - 08/2002
16Myocardial Infarction
04/2022 - 11/2004
15Diabetes Mellitus
01/2021 - 08/2005
13Coronary Artery Disease (Coronary Atherosclerosis)
06/2021 - 12/2003
13Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2021 - 10/2004
11Essential Hypertension
01/2020 - 08/2002
11Insulin Resistance
01/2019 - 08/2002
10Chronic Renal Insufficiency
01/2022 - 12/2010
9Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 03/2009
8COVID-19
01/2022 - 01/2020
8Atrial Fibrillation
06/2021 - 03/2003
8Carotid Artery Diseases
01/2019 - 11/2002
7Renal Insufficiency (Renal Failure)
01/2021 - 12/2004
7Isolated Systolic Hypertension
01/2018 - 01/2003
7Hypoxia (Hypoxemia)
01/2017 - 09/2006
6Hypertrophy
01/2021 - 01/2006
5Erectile Dysfunction
01/2022 - 12/2004
5Fibrosis (Cirrhosis)
11/2021 - 05/2005
5Obstructive Sleep Apnea
01/2019 - 08/2002
5Neoplasms (Cancer)
02/2016 - 04/2011
5Abdominal Obesity
12/2011 - 12/2004
4Infections
01/2022 - 03/2011
4Hemorrhage
06/2021 - 06/2012
4Iron Overload
11/2020 - 08/2002
4Overweight
01/2019 - 12/2008
4Cerebrovascular Disorders (Cerebrovascular Occlusion)
10/2018 - 05/2012
4White Coat Hypertension
08/2015 - 08/2011
4Albuminuria
10/2014 - 07/2011
4Dyslipidemias (Dyslipidemia)
05/2013 - 09/2006
3Left Ventricular Dysfunction
01/2022 - 01/2005
3Body Weight (Weight, Body)
11/2021 - 08/2005
3Diabetes Complications
10/2021 - 01/2018
3Dementia (Dementias)
01/2021 - 10/2012
3Heart Diseases (Heart Disease)
01/2021 - 10/2018
3Weight Loss (Weight Reduction)
01/2021 - 08/2014
3Gout
10/2020 - 09/2015
3Kidney Diseases (Kidney Disease)
10/2020 - 05/2016

Drug/Important Bio-Agent (IBA)

94Antihypertensive Agents (Antihypertensives)IBA
04/2022 - 03/2002
36Glucose (Dextrose)FDA LinkGeneric
01/2022 - 09/2003
35Gliclazide (Diamicron)IBA
01/2022 - 06/2008
34perindopril drug combination indapamideIBA
01/2022 - 04/2009
22Adrenergic Agents (Adrenergic Drugs)IBA
01/2020 - 03/2003
21Telmisartan (Micardis)FDA Link
01/2021 - 03/2008
20Angiotensin Receptor AntagonistsIBA
01/2021 - 09/2003
19Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2022 - 04/2002
19CholesterolIBA
01/2021 - 07/2002
19Atenolol (Tenormin)FDA LinkGeneric
01/2020 - 11/2002
18Pharmaceutical PreparationsIBA
01/2020 - 09/2002
17DiureticsIBA
01/2022 - 03/2002
17CreatinineIBA
01/2022 - 12/2004
16PerindoprilFDA LinkGeneric
01/2022 - 04/2009
15Blood Glucose (Blood Sugar)IBA
01/2022 - 06/2005
15Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2021 - 09/2004
15lacidipineIBA
01/2020 - 11/2002
13Hydrochlorothiazide (Esidrix)FDA LinkGeneric
01/2022 - 09/2003
13IndapamideFDA LinkGeneric
01/2022 - 04/2009
13Ramipril (Altace)FDA LinkGeneric
01/2021 - 03/2008
12Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2020 - 01/2006
10SodiumIBA
01/2022 - 09/2006
10Valsartan (Vals)FDA Link
01/2021 - 04/2002
10Uric Acid (Urate)IBA
10/2020 - 12/2004
10Nifedipine (Adalat)FDA LinkGeneric
01/2016 - 03/2002
8Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2012
8Amlodipine (Norvasc)FDA LinkGeneric
01/2020 - 07/2006
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018 - 02/2010
8CalciumIBA
12/2016 - 11/2002
7Hypoglycemic Agents (Hypoglycemics)IBA
01/2022 - 06/2005
7AlbuminsIBA
01/2021 - 10/2014
7LipidsIBA
01/2021 - 12/2004
7trandolapril (Mavik)FDA LinkGeneric
01/2016 - 12/2003
7Verapamil (Calan)FDA LinkGeneric
01/2016 - 10/2004
6Triglycerides (Triacylglycerol)IBA
01/2019 - 05/2006
5Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
09/2020 - 02/2008
5lercanidipineIBA
01/2019 - 01/2006
5LDL CholesterolIBA
01/2019 - 04/2012
4Drug CombinationsIBA
01/2021 - 03/2016
4Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2020 - 12/2004
4Insulin (Novolin)FDA Link
01/2020 - 09/2003
4Retinaldehyde (Retinal)IBA
01/2018 - 06/2009
4Oxygen (Dioxygen)IBA
01/2018 - 04/2013
4IronIBA
03/2016 - 08/2002
4candesartan cilexetil (Amias)FDA Link
01/2016 - 09/2003
4Endothelins (Endothelin)IBA
04/2007 - 01/2005
3Ferritins (Ferritin)IBA
11/2020 - 08/2002
3NebivololFDA Link
01/2020 - 12/2003

Therapy/Procedure

58Therapeutics
01/2022 - 05/2004
27Denervation
01/2022 - 05/2012
7Glycemic Control
01/2021 - 06/2008
5Drug Therapy (Chemotherapy)
12/2019 - 05/2004
5Catheters
01/2017 - 05/2012
3Kidney Transplantation
01/2021 - 03/2013
3Secondary Prevention
10/2020 - 06/2002